Join Free For Buyer|Sign In
Professional Online Trade Platform for API, Preparation and Pharmaceutical Machinery and Equipment_EN-CPhI.cn
You are here:  Home >>  

News

Editors' Picks
  • MSD’s Keytruda Approved for Marketing in China in 164 Days, China to Speed Up to Enter the New Era
    SDA updated the marketing application status of MSD’s Keytruda to “Approval completed-to be issued certificate”.
  • SDA: Clinical Trials Can be Conducted within 60 Days without being Negated or Questioned
    The State Drug Administration of China (SDA) has recently released the Announcement on Adjusting the Review and Approval

Top Stories

MICROMERITICS INSTRUMENT CORP. ACQUIRES FREEMAN TECHNOLOGY

MICROMERITICS INSTRUMENT CORP. ACQUIRES FREEMAN TECHNOLOGY

Micromeritics Instrument Corporation, a leading global manufacturer of premium products for advanced material characterisation, today announced the...
By:Freeman Technology
2018.06.21

Research & Development

FDA approves RNA therapy for rare genetic disease
FDA approves RNA therapy for rare genetic disease
The US Food and Drug Administration has approved the RNA-based therapy Onpattro, for the treatment of the rare genetic disease polyneuropathy cause...
By:pharmafile
2018.08.14
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53